Intracranial neoplasm

Malignant brain tumors, due to tumor cells will infiltrate surrounding brain tissue, the boundary with normal brain tissue is blurred, therefore, it is not easy to remove completely after surgery. Unless the brain tumor is quite malignant or may spread with the cerebrospinal fluid, generally, only partial irradiation is required.

Changhong Biological Technology Company with Hualien Tzu Chi Hospital sign a letter of intent for cooperation, and commissioned Hualien Tzu Chi Hospital to execute “The Phase I/IIa Human Clinical Trial of Targeted New Drug Cerebraca® Wafer Combined with Temozolomide (TMZ) for Treatment of Malignant Brain Tumors”, the operation went smoothly and successfully, the patient was transferred out of the intensive care unit two days after the operation, he was discharged from hospital a week later.